Virtual CPE: IP, Regulatory and Financing Strategy for Growing Companies During a Pandemic

This program will provide substantiative information relative to the timelines for intellectual property protection and regulatory approvals and how that can impact financing rounds and corporate deals.  Although focused more in the healthcare/ life sciences arena, much will be universal within the IP and regulatory landscape.  In addition to content, there will be a panel discussion relative to best practices, how finance leaders can help companies plan and work through IP and regulatory challenges, as well as the ever-changing regulatory landscape in light of the Covid-19 impact.

Learning Objectives:

• Gain a thorough understanding of the patent prosecution and FDA processes including pitfalls and opportunities
• Understand how regulatory and IP challenges and opportunities can impact fundraising and deals
• Understand how Covid-19 has changed the landscape on the IP, regulatory and financing fronts

The CPE portion of this webinar has concluded, but users can still view the presentation recording for educational purposes.